Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects

Inclusion Criteria: * Healthy male volunteer 19 years to 45 years * Body mass index in the range of 18 to 29 kg/m2 and body weight greater than 50 kg * The subjects personally signed and dated informed consent document after informed of all pertinent aspects of the study, fully understanding and determided spontaneously to participate Exclusion Criteria: * Subject with serious active cardiovascular, respiratory, hepatologic, renal, hematologic, endocrine, urologic, immunologic, dermal, neurologic, or psychological disease or history of such disease * Subject with acute disease within 28 days before the first dose of Investigational product * Subject with known for history of disease which affect on the absorption, distribution, metabolism, excretion of drug * Subjects who are unwilling or unable to use highly effective methods of contraception as outlined in this protocol for the duration of the study